Skip to main content

Table 2 The absolute and relative frequencies of most common clinical manifestations in study subjects according to MEFV genotype group

From: Distribution of MEFV gene mutations and R202Q polymorphism in the Serbian population and their influence on oxidative stress and clinical manifestations of inflammation

Clinical manifestations MEFV mutation carriers (n = 11) R202Q homozygotes (n = 10) MEFV/R202Qhomo (n = 20) Control (n = 76)
Reccurent febrile episodes 8 (72.7 %)* 8 (80 %)* 16 (80 %)** 31 (40.8 %)
Peritonitis 5 (45.5 %)** 3 (30 %) 8 (40 %)** 8 (10.5 %)
Fatigue/malaise 6 (54.5 %)** 4 (40 %) 10 (50 %)** 11 (14.5 %)
Diffuse abdominal pain 7 (63.6 %)* 6 (60 %)* 12 (60 %)** 21 (27.6 %)
Lymphadenopathy 3 (27.3 %) 7 (70 %)* 10 (50 %) 28 (36.8 %)
Oligoarthralgia 5 (45.5 %) 3 (30 %) 8 (40 %) 20 (26.3 %)
Myalgia 3 (27.3 %) 3 (30 %) 6 (30 %) 13 (17.1 %)
  1. Values are shown as n (%)
  2. MEFV/R202Qhomo MEFV mutation carrier plus R202Q homozygotes group, Control N/N and R202Q/N. Data for 4 subjects in control group were missing
  3. *p < 0.05; **p ≤ 0.01 compared to control group